Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Paediatric Vaccine Market by Type (Pneumococcal, Varicella, Combinations, Poliovirus, Hepatitis , MMR , Pediatric Hormones     , HIB, Allergy and Respiratory vaccines, Other Pediatric vaccines), By Application (Age (0-3), Age (3-12), Age Above 12) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Paediatric Vaccine Market by Type (Pneumococcal, Varicella, Combinations, Poliovirus, Hepatitis , MMR , Pediatric Hormones     , HIB, Allergy and Respiratory vaccines, Other Pediatric vaccines), By Application (Age (0-3), Age (3-12), Age Above 12) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130944 3300 Pharma & Healthcare 377 243 Pages 4.9 (43)

Market Overview:

The global paediatric vaccine market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in the paediatric vaccine market can be attributed to factors such as rising incidence of infectious diseases, increasing awareness about vaccination, and technological advancements in the field of paediatric vaccines. Based on type, the global paediatric vaccine market is segmented into pneumococcal vaccines, varicella vaccines, combination vaccines, poliovirus vaccines, hepatitis B virus (HBV) vaccines, measles-mumps-rubella (MMR)vaccines,, Haemophilus influenzae type b (HIB)vaccines,, allergy and respiratory disease vaccines,, and other pediatrician vaccinessuch as rotavirus and meningococcal conjugate vaccine. Pneumococcal Vaccinesegment is projected to grow at the highest CAGR during the forecast period owingto increasing incidence of pneumonia across the globe. Based on application ,the global pediatrician vaccinemarketis segmented into age group 0-3 years old , 3-12 years oldand above 12 years old . Age group 0-3years olds areexpectedtogrowat themost rapidCAGRand reach a valueof US$ XX millionby2030 .

Global Paediatric Vaccine Industry Outlook

Product Definition:

A paediatric vaccine is a vaccine specifically designed to protect infants and young children from disease. Many vaccines are not recommended for use in paediatrics, such as the shingles vaccine, because they have not been tested in children. The importance of paediatric vaccines is that they protect children from diseases that can cause serious illness or death.


Pneumococcal is a vaccine for prevention of pneumonia caused by the bacteria Streptococcus pneumonia. Pneumonia can be life-threatening and requires immediate medical attention. The Centers for Disease Control and Prevention (CDC) recommends routine vaccination against pneumococcal infections in children, especially those who are at risk of developing severe disease or infection.


Varicella is a highly contagious virus and can be transmitted through air by cough, sneeze or even just plain contact with another infected person. The disease has two main stages namely primary and secondary.

Application Insights:

The age group 0-3 years held the largest share of 26.1% in 2017 in the global Paediatric vaccine market. This is due to high immunization coverage against a number of diseases such as DTP, measles, and polio among other vaccines. Immunization programs are carried out during initial months of life against a number of diseases to ensure complete protection from disease onset by providing antibodies generated before exposure to infectious agents.

Immunization at an early age provides lifelong immunity and reduces mortality & morbidity caused by these infections worldwide which is anticipated to propel demand over the forecast period for this segment globally.

Regional Analysis:

North America dominated the global market in 2017. This can be attributed to factors such as high healthcare expenditure, favorable government initiatives, and increasing awareness about vaccines among parents. For instance, according to a study published by the Centers for Disease Control & Prevention (CDC) in 2016; pneumococcal vaccine is recommended for all children between 2 and 23 months old and again between 5 and 21 years of age.

Growth Factors:

  • Increasing incidence of infectious diseases in children
  • Growing awareness about the benefits of vaccination among parents
  • Rising demand for pediatric vaccines from emerging countries
  • Technological advancements in vaccine development and manufacturing processes
  • Expansion of global public-private partnerships for vaccine development

Scope Of The Report

Report Attributes

Report Details

Report Title

Paediatric Vaccine Market Research Report

By Type

Pneumococcal, Varicella, Combinations, Poliovirus, Hepatitis , MMR , Pediatric Hormones     , HIB, Allergy and Respiratory vaccines, Other Pediatric vaccines

By Application

Age (0-3), Age (3-12), Age Above 12

By Companies

GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Pfizer, F. Hoffmann-La Roche, Novo Nordisk

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Paediatric Vaccine Market Report Segments:

The global Paediatric Vaccine market is segmented on the basis of:


Pneumococcal, Varicella, Combinations, Poliovirus, Hepatitis , MMR , Pediatric Hormones     , HIB, Allergy and Respiratory vaccines, Other Pediatric vaccines

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Age (0-3), Age (3-12), Age Above 12

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GlaxoSmithCline
  2. Merck
  3. Sanofi
  4. Bristol-Myers Squibb
  5. Abbott Laboratories
  6. Eli Lilly
  7. Pfizer
  8. F. Hoffmann-La Roche
  9. Novo Nordisk

Global Paediatric Vaccine Market Overview

Highlights of The Paediatric Vaccine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Pneumococcal
    2. Varicella
    3. Combinations
    4. Poliovirus
    5. Hepatitis 
    6. MMR 
    7. Pediatric Hormones     
    8. HIB
    9. Allergy and Respiratory vaccines
    10. Other Pediatric vaccines
  1. By Application:

    1. Age (0-3)
    2. Age (3-12)
    3. Age Above 12
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Paediatric Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Paediatric Vaccine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Paediatric Vaccine Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Paediatric Vaccine Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Paediatric Vaccine Market - Supply Chain
   4.5. Global Paediatric Vaccine Market Forecast
      4.5.1. Paediatric Vaccine Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Paediatric Vaccine Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Paediatric Vaccine Market Absolute $ Opportunity

5. Global Paediatric Vaccine Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Paediatric Vaccine Market Size and Volume Forecast by Type
      5.3.1. Pneumococcal
      5.3.2. Varicella
      5.3.3. Combinations
      5.3.4. Poliovirus
      5.3.5. Hepatitis 
      5.3.6. MMR 
      5.3.7. Pediatric Hormones     
      5.3.8. HIB
      5.3.9. Allergy and Respiratory vaccines
      5.3.10.   Other Pediatric vaccines
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Paediatric Vaccine Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Paediatric Vaccine Market Size and Volume Forecast by Application
      6.3.1. Age (0-3)
      6.3.2. Age (3-12)
      6.3.3. Age Above 12
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Paediatric Vaccine Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Paediatric Vaccine Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Paediatric Vaccine Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Paediatric Vaccine Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Paediatric Vaccine Demand Share Forecast, 2019-2029

9. North America Paediatric Vaccine Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Paediatric Vaccine Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Paediatric Vaccine Market Size and Volume Forecast by Application
      9.4.1. Age (0-3)
      9.4.2. Age (3-12)
      9.4.3. Age Above 12
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Paediatric Vaccine Market Size and Volume Forecast by Type
      9.7.1. Pneumococcal
      9.7.2. Varicella
      9.7.3. Combinations
      9.7.4. Poliovirus
      9.7.5. Hepatitis 
      9.7.6. MMR 
      9.7.7. Pediatric Hormones     
      9.7.8. HIB
      9.7.9. Allergy and Respiratory vaccines
      9.7.10.   Other Pediatric vaccines
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Paediatric Vaccine Demand Share Forecast, 2019-2029

10. Latin America Paediatric Vaccine Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Paediatric Vaccine Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Paediatric Vaccine Market Size and Volume Forecast by Application
      10.4.1. Age (0-3)
      10.4.2. Age (3-12)
      10.4.3. Age Above 12
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Paediatric Vaccine Market Size and Volume Forecast by Type
      10.7.1. Pneumococcal
      10.7.2. Varicella
      10.7.3. Combinations
      10.7.4. Poliovirus
      10.7.5. Hepatitis 
      10.7.6. MMR 
      10.7.7. Pediatric Hormones     
      10.7.8. HIB
      10.7.9. Allergy and Respiratory vaccines
      10.7.10.   Other Pediatric vaccines
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Paediatric Vaccine Demand Share Forecast, 2019-2029

11. Europe Paediatric Vaccine Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Paediatric Vaccine Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Paediatric Vaccine Market Size and Volume Forecast by Application
      11.4.1. Age (0-3)
      11.4.2. Age (3-12)
      11.4.3. Age Above 12
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Paediatric Vaccine Market Size and Volume Forecast by Type
      11.7.1. Pneumococcal
      11.7.2. Varicella
      11.7.3. Combinations
      11.7.4. Poliovirus
      11.7.5. Hepatitis 
      11.7.6. MMR 
      11.7.7. Pediatric Hormones     
      11.7.8. HIB
      11.7.9. Allergy and Respiratory vaccines
      11.7.10.   Other Pediatric vaccines
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Paediatric Vaccine Demand Share, 2019-2029

12. Asia Pacific Paediatric Vaccine Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Paediatric Vaccine Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Paediatric Vaccine Market Size and Volume Forecast by Application
      12.4.1. Age (0-3)
      12.4.2. Age (3-12)
      12.4.3. Age Above 12
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Paediatric Vaccine Market Size and Volume Forecast by Type
      12.7.1. Pneumococcal
      12.7.2. Varicella
      12.7.3. Combinations
      12.7.4. Poliovirus
      12.7.5. Hepatitis 
      12.7.6. MMR 
      12.7.7. Pediatric Hormones     
      12.7.8. HIB
      12.7.9. Allergy and Respiratory vaccines
      12.7.10.   Other Pediatric vaccines
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Paediatric Vaccine Demand Share, 2019-2029

13. Middle East & Africa Paediatric Vaccine Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Paediatric Vaccine Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Paediatric Vaccine Market Size and Volume Forecast by Application
      13.4.1. Age (0-3)
      13.4.2. Age (3-12)
      13.4.3. Age Above 12
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Paediatric Vaccine Market Size and Volume Forecast by Type
      13.7.1. Pneumococcal
      13.7.2. Varicella
      13.7.3. Combinations
      13.7.4. Poliovirus
      13.7.5. Hepatitis 
      13.7.6. MMR 
      13.7.7. Pediatric Hormones     
      13.7.8. HIB
      13.7.9. Allergy and Respiratory vaccines
      13.7.10.   Other Pediatric vaccines
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Paediatric Vaccine Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Paediatric Vaccine Market: Market Share Analysis
   14.2. Paediatric Vaccine Distributors and Customers
   14.3. Paediatric Vaccine Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GlaxoSmithCline Overview Financials Developments Strategic Outlook
      14.4.2. Merck Overview Financials Developments Strategic Outlook
      14.4.3. Sanofi Overview Financials Developments Strategic Outlook
      14.4.4. Bristol-Myers Squibb Overview Financials Developments Strategic Outlook
      14.4.5. Abbott Laboratories Overview Financials Developments Strategic Outlook
      14.4.6. Eli Lilly Overview Financials Developments Strategic Outlook
      14.4.7. Pfizer Overview Financials Developments Strategic Outlook
      14.4.8. F. Hoffmann-La Roche Overview Financials Developments Strategic Outlook
      14.4.9. Novo Nordisk Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us